CellBion Co., Ltd. (KOSDAQ:308430)
South Korea
· Delayed Price · Currency is KRW
37,700
-250 (-0.66%)
At close: Apr 28, 2026
CellBion Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 27, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 483,748 | 302,824 | 151,052 | - | - | - | |
| Market Cap Growth | 118.06% | 100.48% | - | - | - | - | |
| Enterprise Value | 469,460 | 281,704 | 148,393 | - | - | - | |
| Last Close Price | 37700.00 | 23600.00 | 11800.00 | - | - | - | |
| PS Ratio | 248.70 | 155.69 | 65.97 | - | - | - | |
| PB Ratio | 21.23 | 13.29 | 5.11 | - | - | - | |
| P/TBV Ratio | 21.96 | 13.75 | 5.22 | - | - | - | |
| EV/Sales Ratio | 241.36 | 144.83 | 64.81 | - | - | - | |
| Debt / Equity Ratio | 0.37 | 0.37 | 0.07 | 0.07 | 1.01 | 0.27 | |
| Net Debt / Equity Ratio | -0.63 | -0.63 | -0.96 | -0.91 | -0.96 | -1.00 | |
| Net Debt / EBITDA Ratio | 1.79 | 1.79 | 4.10 | 1.41 | 0.53 | 2.17 | |
| Net Debt / FCF Ratio | 2.04 | 2.04 | 5.79 | 1.61 | 0.52 | 2.36 | |
| Asset Turnover | 0.06 | 0.06 | 0.10 | 0.14 | 0.15 | 0.09 | |
| Inventory Turnover | 4.42 | 4.42 | 2.68 | 1.95 | 2.99 | 3.29 | |
| Quick Ratio | 10.28 | 10.28 | 29.00 | 5.07 | 1.07 | 2.97 | |
| Current Ratio | 11.10 | 11.10 | 29.58 | 5.85 | 1.43 | 3.21 | |
| Return on Equity (ROE) | -28.93% | -28.93% | -39.20% | -70.98% | -113.85% | -88.37% | |
| Return on Assets (ROA) | -14.81% | -14.81% | -19.50% | -29.48% | -27.75% | -26.85% | |
| Return on Capital Employed (ROCE) | -25.00% | -25.00% | -21.40% | -51.40% | -111.40% | -44.50% | |
| Earnings Yield | -1.57% | -2.50% | -4.81% | - | - | - | |
| FCF Yield | -1.45% | -2.32% | -3.25% | - | - | - | |
| Buyback Yield / Dilution | -26.24% | -26.24% | -2.27% | -2.28% | -10.36% | -1.48% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.